Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             30 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A bacterial strain with the deletion of a prophage gene only in the plasmid also showed diminished antibiotic resistance Cho, Yun Young

57 3 p.
artikel
2 Antibiotic strategies and clinical outcomes for patients with carbapenem-resistant Gram-negative bacterial bloodstream infection Qu, Junyan

57 3 p.
artikel
3 Azithromycin, a questionable treatment for COVID-19 Belfaqeeh, O.

57 3 p.
artikel
4 Balanced evaluation of preliminary data on a candidate COVID-19 hydroxychloroquine treatment Seligmann, Hervé

57 3 p.
artikel
5 Chloroquine for treatment of COVID-19 results in subtherapeutic exposure and prolonged QTc intervals Brüggemann, R.J.

57 3 p.
artikel
6 Combatting the Rising Tide of Antimicrobial Resistance: Pharmacokinetic/Pharmacodynamic Dosing Strategies for Maximal Precision Chua, Hubert C.

57 3 p.
artikel
7 Comparison of two empirical prolonged infusion dosing regimens for meropenem in patients with septic shock: A two-center pilot study Eisert, Albrecht

57 3 p.
artikel
8 Co-occurrence of mcr-1 and mcr-8 genes in multi-drug-resistant Klebsiella pneumoniae from a 2015 clinical isolate Hala, S.

57 3 p.
artikel
9 Determination of vancomycin exposure target and individualised dosing recommendations for neonates: model-informed precision dosing Tang, Zhe

57 3 p.
artikel
10 Dysbiosis of the rat vagina is efficiently rescued by vaginal microbiota transplantation or probiotic combination Chen, Tingtao

57 3 p.
artikel
11 Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann Gautret, Philippe

57 3 p.
artikel
12 Escherichia coli prophage sequences are not present in a carbapenemase plasmid from Klebsiella. Reply to Authors' response to Letter to the Editor: If extraordinary data are not first corroborated, we risk being led astray: Occam's razor does not support the existence of plasmid-prophage chimeras. Comment on ‘Effects of cryptic prophage regions in a plasmid carrying a carbapenemase gene on survival against antibiotic stress’ Jobling, Michael G.

57 3 p.
artikel
13 Evaluating the emergence of nonsusceptibility among Pseudomonas aeruginosa respiratory isolates from a phase-3 clinical trial for treatment of nosocomial pneumonia (ASPECT-NP) Johnson, Matthew G.

57 3 p.
artikel
14 Genomic analysis of VIM-2-producing Enterobacter hormaechei subsp. steigerwaltii Bonnin, Rémy A.

57 3 p.
artikel
15 High carriage of ESBL-producing Enterobacteriaceae associated with sexual activity among men who have sex with men van Bilsen, Ward P.H.

57 3 p.
artikel
16 Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine Plaze, Marion

57 3 p.
artikel
17 International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page
57 3 p.
artikel
18 In-vitro pharmacokinetic/pharmacodynamic model data suggest a potential role of new formulations of posaconazole against Candida krusei but not Candida glabrata infections Beredaki, Maria-Ioanna

57 3 p.
artikel
19 Multicenter study of ceftolozane/tazobactam for treatment of Pseudomonas aeruginosa infections in critically ill patients Balandin, Bárbara

57 3 p.
artikel
20 Outcomes associated with recent guideline recommendations removing metronidazole for treatment of non-severe Clostridioides difficile infection: a retrospective, observational, nationwide cohort study Gentry, Chris A.

57 3 p.
artikel
21 Passive immunization and its rebirth in the era of the COVID-19 pandemic Pavia, Charles S.

57 3 p.
artikel
22 Pharmacokinetics of colistin in cerebrospinal fluid after intraventricular administration alone in intracranial infections Ni, Min

57 3 p.
artikel
23 Pharmacotherapy for Bordetella pertussis infection. I. A synthesis of laboratory sciences Cimolai, Nevio

57 3 p.
artikel
24 Pharmacotherapy for Bordetella pertussis infection. II. A synthesis of clinical sciences Cimolai, Nevio

57 3 p.
artikel
25 Reply to the letter to the editor “Azithromycin, treatment in COVID-19” Manafi, Navid

57 3 p.
artikel
26 Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses? Trentalange, Alice

57 3 p.
artikel
27 Seven-year surveillance of the prevalence of antimicrobial-resistant Escherichia coli isolates, with a focus on ST131 clones, among healthy people in Osaka, Japan Fukuda, Akira

57 3 p.
artikel
28 Short-cycle therapy (5 days on/2 days off) with a lamivudine + dolutegravir regimen in a cohort of virologically suppressed patients with HIV infection Lanzafame, Massimiliano

57 3 p.
artikel
29 The Novel Membrane-Associated Auxiliary Factors AuxA and AuxB Modulate β-lactam Resistance in MRSA by stabilizing Lipoteichoic Acids Mikkelsen, Kasper

57 3 p.
artikel
30 Title Page & Editorial Board
57 3 p.
artikel
                             30 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland